HCN: The Most Exciting Internet Powered Network We’ve Seen Launched in Decades.
Is Privately Held Hotel Communications Network Following the Footsteps of FaceBook (FB)?.
(Secret: Where Facebook started on a college campus and landed one student after...
Crazy Valuations at Lyft? $20 Billion for $2 Billion in Rev’s (Quartz).
Lyft warns it may never make any money.
“We have a history of net losses and we may not be able to achieve or maintain...
The Hottest Wearable Tech and Smart Gadgets of 2016
All right. Well, take care yourself. I guess that's what you're best, presence old master? A tremor in the Force. The last time felt...
Dyadic (DYAI) Announces Effectiveness of Form 10 Registration Statement and Application to NASDAQ
JUPITER, FL / ACCESSWIRE / February 13, 2019 / Dyadic International, Inc. (the "Company") (OTCQX: DYAI) today announced that the Securities and Exchange Commission (the...
Adding Mustang Bio (MBIO) $4.00 to Watchlist After Investor Presentation.
We met with management at Company-sponsored lunch at Ruth Chris in Boca Raton last week and we came away extremely enthusiastic about the Company's...
Galaxy Next Generation (GAXY) Commitment of $600,000 From a Single School District!
Galaxy Next Generation Announces Commitment of $600k from the School District of Brooks County, Ga for More than 150 G2 Slim Touch Panels.
OCCOA, Ga.,...
NanoVibronix (NAOV) $3.35, Gets $10.50 Price target from Dawson James.
Click here for report.
Dr Lindsay Rosenwald, Biography.
Wall Street Transcript Interview (2018)
IDB Bank Profile
Biography (2011) LR Facts*, below.
For almost twenty years, Dr. Lindsay Rosenwald has been building a positive reputation within the...
Orchestra BioMed™ Announces Completion of $41 Million Financing.
November 15, 2018
Capital proceeds to support late-stage clinical development of lead cardiovascular product candidates for artery disease and hypertensionFinancing structure provides for up to...
Immunomedics Chairman Buys $19 Million More in Stock.
(Barrons) Two weeks ago, B. Riley analyst Madhu Kumar gushed about Immunomedics, writing in a report that the biotech could have a “blockbuster cancer drug” in IMMU-132, an antibody-drug...
